
Is DXCM (DexCom, Inc.) Halal or Haram?
DexCom easily passes all AAOIFI shariah screening criteria, making it a fully compliant investment. The company operates with a very conservative capital structure, carrying a debt-to-market cap ratio of just 6.1%, well below the 33% threshold. Furthermore, its interest income is negligible at 0.00% of revenue, ensuring investors are not exposed to impermissible financial gains.
Price Chart (5D)
DXCM — Last 7 Days
| Date | Open | High | Low | Close | Volume | Change |
|---|---|---|---|---|---|---|
| 2026-05-01 | 60.99 | 62.85 | 59.70 | 61.35 | 10.6M | +0.59% |
| 2026-04-30 | 57.88 | 59.64 | 57.58 | 59.55 | 5.3M | +2.89% |
| 2026-04-29 | 58.95 | 58.95 | 56.72 | 57.56 | 6.6M | -2.36% |
| 2026-04-28 | 61.68 | 62.44 | 59.09 | 59.32 | 5.6M | -3.83% |
| 2026-04-27 | 61.12 | 62.08 | 61.04 | 61.41 | 3.4M | +0.47% |
| 2026-04-24 | 62.67 | 62.90 | 60.34 | 61.57 | 3.6M | -1.76% |
| 2026-04-23 | 63.09 | 63.78 | 61.90 | 62.70 | 2.5M | -0.62% |
Discussion
Sign in to join the discussion
Loading comments...
Shariah Screening Details for DXCM
Business Activity
Permissible
DexCom's core business of developing continuous glucose monitoring systems like the DexCom G6 for diabetes management is entirely permissible and aligns with Islamic principles of preserving health.
Debt / Market Cap
6.07%
Interest Income
0.00%
Cash & Securities
8.73%
About DexCom, Inc. (DXCM)
DexCom, Inc. is a leading medical device company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Their flagship products, including the DexCom G6 and Dexcom ONE, eliminate the need for traditional finger-stick blood tests, significantly improving the quality of life for patients globally.
For Muslim investors, DexCom represents a strong Halal investment opportunity as it successfully passes all four AAOIFI shariah screens. The company's core business of healthcare technology is inherently permissible, and its financial structure strictly adheres to Islamic finance guidelines, meaning investors can confidently add this stock to their halal portfolios.
From an Islamic finance perspective, DexCom's financial health is exceptionally robust. The company maintains very low leverage with a debt-to-market cap ratio of just 6.1%, and its cash and securities sit comfortably at 8.7% of its market capitalization. Notably, it generates zero non-compliant interest income, keeping its revenue stream pure.
Because the medical device industry is generally free of shariah controversies, there is no significant scholarly debate regarding DexCom's core operations. However, halal investors should continue to monitor its quarterly financial reports to ensure its debt levels remain well below the 33% threshold as the company expands internationally.
CEO
Jacob Steven Leach
Employees
10,200
IPO Date
2005-04-14
Headquarters
San Diego, CA, US
Website
www.dexcom.comDXCM Key Financial Statistics
Revenue
$4.66B
Net Income
$836.3M
EPS (Diluted)
$2.09
Stock Price
59.32
Beta
1.56
52-Week Range
54.11-89.98
Total Debt
$1.39B
Total Equity
$2.75B
Current Ratio
1.88
DXCM Financial Health & Profitability
Profit Margins
Revenue Growth (YoY)
+15.6%
Prior year: $4.03B
Net Debt
$472.0M
Cash: $917.7M — Debt: $1.39B
R&D Spending
$599.1M
% of Revenue
12.9%
Frequently Asked Questions About DXCM
Is DXCM (DexCom, Inc.) stock halal to invest in?▾
What does DexCom, Inc. do?▾
What screening criteria were used for DXCM?▾
Does DXCM require income purification?▾
When was DXCM last screened?▾
Disclaimer
This shariah compliance assessment for DXCM (DexCom, Inc.) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.